[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

China Hib Vaccine Market Research Report 2018

March 2018 | 102 pages | ID: CC2C7A432E8QEN
QYResearch

US$ 3,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Hib Vaccine market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Hib Vaccine development status and future trend in China, focuses on top players in China, also splits Hib Vaccine by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
  • Novartis
  • Merck
  • Sanofi
  • GSK
  • Takeda Pharmaceutical Company Limited
  • China National Pharmaceutical Group Corporation
  • China Biotechnology Group Corporation
  • Bio Kang Tai
  • Walvax Biotechnology
Geographically, this report splits the China market into six regions,
  • South China
  • East China
  • Southwest China
  • Northeast China
  • North China
  • Central China
  • Northwest China
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
  • Type I
  • Type II
On the basis of the end users/application, this report covers
  • Hospital
  • Research & Academic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
China Hib Vaccine Market Research Report 2018

1 HIB VACCINE OVERVIEW

1.1 Product Overview and Scope of Hib Vaccine
1.2 Classification of Hib Vaccine by Product Category
  1.2.1 China Hib Vaccine Sales (K Units) Comparison by Type (2013-2025)
  1.2.2 China Hib Vaccine Sales (K Units) Market Share by Type in 2017
  1.2.3
  1.2.4
1.3 China Hib Vaccine Market by Application/End Users
  1.3.1 China Hib Vaccine Sales (K Units) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Hospital
  1.3.3 Research & Academic Laboratories
  1.3.4 Pharmaceutical & Biotechnology Companies
  1.3.5 Others
1.4 China Hib Vaccine Market by Region
  1.4.1 China Hib Vaccine Market Size (Million USD) Comparison by Region (2013-2025)
  1.4.2 South China Hib Vaccine Status and Prospect (2013-2025)
  1.4.3 East China Hib Vaccine Status and Prospect (2013-2025)
  1.4.4 Southwest China Hib Vaccine Status and Prospect (2013-2025)
  1.4.5 Northeast China Hib Vaccine Status and Prospect (2013-2025)
  1.4.6 North China Hib Vaccine Status and Prospect (2013-2025)
  1.4.7 Central China Hib Vaccine Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of Hib Vaccine (2013-2025)
  1.5.1 China Hib Vaccine Sales (K Units) and Growth Rate (%)(2013-2025)
  1.5.2 China Hib Vaccine Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 CHINA HIB VACCINE MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Hib Vaccine Sales and Market Share of Key Players/Manufacturers (2013-2018)
2.2 China Hib Vaccine Revenue and Share by Players/Manufacturers (2013-2018)
2.3 China Hib Vaccine Average Price (USD/Unit) by Players/Manufacturers (2013-2018)
2.4 China Hib Vaccine Market Competitive Situation and Trends
  2.4.1 China Hib Vaccine Market Concentration Rate
  2.4.2 China Hib Vaccine Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Hib Vaccine Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA HIB VACCINE SALES AND REVENUE BY REGION (2013-2018)

3.1 China Hib Vaccine Sales (K Units) and Market Share by Region (2013-2018)
3.2 China Hib Vaccine Revenue (Million USD) and Market Share by Region (2013-2018)
3.3 China Hib Vaccine Price (USD/Unit) by Regions (2013-2018)

4 CHINA HIB VACCINE SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2013-2018)

4.1 China Hib Vaccine Sales (K Units) and Market Share by Type/ Product Category (2013-2018)
4.2 China Hib Vaccine Revenue (Million USD) and Market Share by Type (2013-2018)
4.3 China Hib Vaccine Price (USD/Unit) by Type (2013-2018)
4.4 China Hib Vaccine Sales Growth Rate (%) by Type (2013-2018)

5 CHINA HIB VACCINE SALES BY APPLICATION (2013-2018)

5.1 China Hib Vaccine Sales (K Units) and Market Share by Application (2013-2018)
5.2 China Hib Vaccine Sales Growth Rate (%) by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 CHINA HIB VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Hib Vaccine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Merck
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Hib Vaccine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Merck Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Sanofi
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Hib Vaccine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Sanofi Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.3.4 Main Business/Business Overview
6.4 GSK
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Hib Vaccine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 GSK Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Takeda Pharmaceutical Company Limited
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Hib Vaccine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Takeda Pharmaceutical Company Limited Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.5.4 Main Business/Business Overview
6.6 China National Pharmaceutical Group Corporation
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Hib Vaccine Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 China National Pharmaceutical Group Corporation Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.6.4 Main Business/Business Overview
6.7 China Biotechnology Group Corporation
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Hib Vaccine Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 China Biotechnology Group Corporation Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Bio Kang Tai
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Hib Vaccine Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bio Kang Tai Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Walvax Biotechnology
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Hib Vaccine Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Walvax Biotechnology Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.9.4 Main Business/Business Overview

7 HIB VACCINE MANUFACTURING COST ANALYSIS

7.1 Hib Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Hib Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Hib Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Hib Vaccine Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA HIB VACCINE MARKET SIZE (SALES AND REVENUE) FORECAST (2018-2025)

11.1 China Hib Vaccine Sales (K Units), Revenue (Million USD) Forecast (2018-2025)
11.2 China Hib Vaccine Sales (K Units) Forecast by Type (2018-2025)
11.3 China Hib Vaccine Sales (K Units) Forecast by Application (2018-2025)
11.4 China Hib Vaccine Sales (K Units) Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2013-2025)
Table Hib Vaccine Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Hib Vaccine Sales (K Units) by Application (2013-2025)
Figure Product Picture of Hib Vaccine
Table China Hib Vaccine Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)
Figure China Hib Vaccine Sales Volume Market Share by Types in 2017
Figure Type I Product Picture
Figure Type II Product Picture
Figure China Hib Vaccine Sales (K Units) Comparison by Application (2013-2025)
Figure China Sales Market Share (%) of Hib Vaccine by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Research & Academic Laboratories Examples
Table Key Downstream Customer in Research & Academic Laboratories
Figure Pharmaceutical & Biotechnology Companies Examples
Table Key Downstream Customer in Pharmaceutical & Biotechnology Companies
Figure Others Examples
Table Key Downstream Customer in Others
Figure South China Hib Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure East China Hib Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest China Hib Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Northeast China Hib Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure North China Hib Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Central China Hib Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Hib Vaccine Sales (K Units) and Growth Rate (%)(2013-2025)
Figure China Hib Vaccine Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table China Hib Vaccine Sales of Key Players/Manufacturers (2013-2018)
Table China Hib Vaccine Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Hib Vaccine Sales Share (%) by Players/Manufacturers
Figure 2017 China Hib Vaccine Sales Share (%) by Players/Manufacturers
Table China Hib Vaccine Revenue by Players/Manufacturers (2013-2018)
Table China Hib Vaccine Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Hib Vaccine Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Hib Vaccine Revenue Market Share (%) by Players/Manufacturers
Table China Market Hib Vaccine Average Price of Key Players/Manufacturers (2013-2018)
Figure China Market Hib Vaccine Average Price of Key Players/Manufacturers in 2017
Figure China Hib Vaccine Market Share of Top 3 Players/Manufacturers
Figure China Hib Vaccine Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Hib Vaccine Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Hib Vaccine Product Category
Table China Hib Vaccine Sales (K Units) by Regions (2013-2018)
Table China Hib Vaccine Sales Share (%) by Regions (2013-2018)
Figure China Hib Vaccine Sales Share (%) by Regions (2013-2018)
Figure China Hib Vaccine Sales Market Share (%) by Regions in 2017
Table China Hib Vaccine Revenue (Million USD) and Market Share by Regions (2013-2018)
Table China Hib Vaccine Revenue Market Share (%) by Regions (2013-2018)
Figure China Hib Vaccine Revenue Market Share (%) by Regions (2013-2018)
Figure China Hib Vaccine Revenue Market Share (%) by Regions in 2017
Table China Hib Vaccine Price (USD/Unit) by Regions (2013-2018)
Table China Hib Vaccine Sales (K Units) by Type (2013-2018)
Table China Hib Vaccine Sales Share (%) by Type (2013-2018)
Figure China Hib Vaccine Sales Share (%) by Type (2013-2018)
Figure China Hib Vaccine Sales Market Share (%) by Type in 2017
Table China Hib Vaccine Revenue (Million USD) and Market Share by Type (2013-2018)
Table China Hib Vaccine Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Hib Vaccine by Type (2013-2018)
Figure Revenue Market Share of Hib Vaccine by Type in 2017
Table China Hib Vaccine Price (USD/Unit) by Types (2013-2018)
Figure China Hib Vaccine Sales Growth Rate (%) by Type (2013-2018)
Table China Hib Vaccine Sales (K Units) by Applications (2013-2018)
Table China Hib Vaccine Sales Market Share (%) by Applications (2013-2018)
Figure China Hib Vaccine Sales Market Share (%) by Application (2013-2018)
Figure China Hib Vaccine Sales Market Share (%) by Application in 2017
Table China Hib Vaccine Sales Growth Rate (%) by Application (2013-2018)
Figure China Hib Vaccine Sales Growth Rate (%) by Application (2013-2018)
Table Novartis Hib Vaccine Basic Information List
Table Novartis Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Novartis Hib Vaccine Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Novartis Hib Vaccine Sales Market Share (%) in China (2013-2018)
Figure Novartis Hib Vaccine Revenue Market Share (%) in China (2013-2018)
Table Merck Hib Vaccine Basic Information List
Table Merck Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Merck Hib Vaccine Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Merck Hib Vaccine Sales Market Share (%) in China (2013-2018)
Figure Merck Hib Vaccine Revenue Market Share (%) in China (2013-2018)
Table Sanofi Hib Vaccine Basic Information List
Table Sanofi Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Sanofi Hib Vaccine Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Sanofi Hib Vaccine Sales Market Share (%) in China (2013-2018)
Figure Sanofi Hib Vaccine Revenue Market Share (%) in China (2013-2018)
Table GSK Hib Vaccine Basic Information List
Table GSK Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure GSK Hib Vaccine Sales (K Units) and Growth Rate (%)(2013-2018)
Figure GSK Hib Vaccine Sales Market Share (%) in China (2013-2018)
Figure GSK Hib Vaccine Revenue Market Share (%) in China (2013-2018)
Table Takeda Pharmaceutical Company Limited Hib Vaccine Basic Information List
Table Takeda Pharmaceutical Company Limited Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Takeda Pharmaceutical Company Limited Hib Vaccine Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Takeda Pharmaceutical Company Limited Hib Vaccine Sales Market Share (%) in China (2013-2018)
Figure Takeda Pharmaceutical Company Limited Hib Vaccine Revenue Market Share (%) in China (2013-2018)
Table China National Pharmaceutical Group Corporation Hib Vaccine Basic Information List
Table China National Pharmaceutical Group Corporation Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure China National Pharmaceutical Group Corporation Hib Vaccine Sales (K Units) and Growth Rate (%)(2013-2018)
Figure China National Pharmaceutical Group Corporation Hib Vaccine Sales Market Share (%) in China (2013-2018)
Figure China National Pharmaceutical Group Corporation Hib Vaccine Revenue Market Share (%) in China (2013-2018)
Table China Biotechnology Group Corporation Hib Vaccine Basic Information List
Table China Biotechnology Group Corporation Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure China Biotechnology Group Corporation Hib Vaccine Sales (K Units) and Growth Rate (%)(2013-2018)
Figure China Biotechnology Group Corporation Hib Vaccine Sales Market Share (%) in China (2013-2018)
Figure China Biotechnology Group Corporation Hib Vaccine Revenue Market Share (%) in China (2013-2018)
Table Bio Kang Tai Hib Vaccine Basic Information List
Table Bio Kang Tai Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Bio Kang Tai Hib Vaccine Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Bio Kang Tai Hib Vaccine Sales Market Share (%) in China (2013-2018)
Figure Bio Kang Tai Hib Vaccine Revenue Market Share (%) in China (2013-2018)
Table Walvax Biotechnology Hib Vaccine Basic Information List
Table Walvax Biotechnology Hib Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Walvax Biotechnology Hib Vaccine Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Walvax Biotechnology Hib Vaccine Sales Market Share (%) in China (2013-2018)
Figure Walvax Biotechnology Hib Vaccine Revenue Market Share (%) in China (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hib Vaccine
Figure Manufacturing Process Analysis of Hib Vaccine
Figure Hib Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Hib Vaccine Major Players/Manufacturers in 2017
Table Major Buyers of Hib Vaccine
Table Distributors/Traders List
Figure China Hib Vaccine Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure China Hib Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Hib Vaccine Price (USD/Unit) Trend Forecast (2018-2025)
Table China Hib Vaccine Sales (K Units) Forecast by Type (2018-2025)
Figure China Hib Vaccine Sales (K Units) Forecast by Type (2018-2025)
Figure China Hib Vaccine Sales Volume Market Share Forecast by Type in 2025
Table China Hib Vaccine Sales (K Units) Forecast by Application (2018-2025)
Figure China Hib Vaccine Sales Volume Market Share Forecast by Application (2018-2025)
Figure China Hib Vaccine Sales Volume Market Share Forecast by Application in 2025
Table China Hib Vaccine Sales (K Units) Forecast by Regions (2018-2025)
Table China Hib Vaccine Sales Volume Share Forecast by Regions (2018-2025)
Figure China Hib Vaccine Sales Volume Share Forecast by Regions (2018-2025)
Figure China Hib Vaccine Sales Volume Share Forecast by Regions in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications